SU1718766A1 - Method for preserving the blood erythrocytes - Google Patents

Method for preserving the blood erythrocytes Download PDF

Info

Publication number
SU1718766A1
SU1718766A1 SU904806438A SU4806438A SU1718766A1 SU 1718766 A1 SU1718766 A1 SU 1718766A1 SU 904806438 A SU904806438 A SU 904806438A SU 4806438 A SU4806438 A SU 4806438A SU 1718766 A1 SU1718766 A1 SU 1718766A1
Authority
SU
USSR - Soviet Union
Prior art keywords
solution
cells
glucose
ethyl alcohol
sorbitol
Prior art date
Application number
SU904806438A
Other languages
Russian (ru)
Inventor
Ася Ивановна Ионова
Наталия Витальевна Минеева
Кира Николаевна Климова
Original Assignee
Ленинградский научно-исследовательский институт гематологии и переливания крови
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ленинградский научно-исследовательский институт гематологии и переливания крови filed Critical Ленинградский научно-исследовательский институт гематологии и переливания крови
Priority to SU904806438A priority Critical patent/SU1718766A1/en
Application granted granted Critical
Publication of SU1718766A1 publication Critical patent/SU1718766A1/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Изобретение относитс  к консервированию клеток крови, в частности эритроцитов дл  изосерологических исследований. Целью изобретени   вл етс  упрощение способа путем исключени  энергоемких операций. Эритромассу получают открытым способом, в том числе из крови, вз той без стабилизирующего раствора, клетки отмывают несколько раз 0,9%-ным раствором хлористого натри  и осуществл ют консервирование в растворе, содержащем, в мас.%: сорбит 4,0 ±1,0; глюкозу 0,6± 0,05; N32HP04 -12Н20 0,2; этиловый спирт 96% 9,4± 0,4; левомицетин 0,05± 0,01, воду би- дистиллированную до 100. При сохранении специфических свойств клеток предлагаемый способ позвол ет исключить операцию стерилизации в автоклаве и операцию отсасывани  плазмы со стабилизирующим раствором и разлива эритроцитов с помощью стерильных систем и герметичного укупори- вани . 1 табл. ЈThe invention relates to the preservation of blood cells, in particular, red blood cells for isoserological studies. The aim of the invention is to simplify the process by eliminating energy-intensive operations. Erythromass is obtained by an open method, including from blood taken without a stabilizing solution, the cells are washed several times with 0.9% sodium chloride solution and preserved in a solution containing, in wt.%: Sorbitol 4.0 ± 1 , 0; glucose 0,6 ± 0,05; N32HP04 -12H20 0.2; ethyl alcohol 96% 9.4 ± 0.4; chloramphenicol 0.05 ± 0.01, bi-distilled water up to 100. While maintaining the specific properties of the cells, the proposed method eliminates sterilization in the autoclave and the operation of suctioning the plasma with stabilizing solution and spilling of erythrocytes using sterile systems and sealing. 1 tab. J

Description

Изобретение относитс  к консервированию клеток крови, а именно эритроцитов дл  изосерологических исследований (малыми дозами).This invention relates to the preservation of blood cells, namely, erythrocytes for isoserological studies (in small doses).

Цель изобретени  - упрощение способа за счет исключени  энергоемких операций.The purpose of the invention is to simplify the process by eliminating energy-intensive operations.

Поставленна  цель достигаетс  тем, что эритромассу получают открытым способом, в том числе из крови, вз той без стабилизирующего раствора, клетки отмывают четырехкратно 0,9%-ным раствором хлористого натри , а консервирование осуществл ют в растворе, дополнительно содержащем салициловую кислоту.This goal is achieved by the fact that erythromass is obtained by an open method, including from blood taken without a stabilizing solution, cells are washed four times with 0.9% sodium chloride solution, and preservation is carried out in a solution that additionally contains salicylic acid.

Способ осуществл ют следующим образом .The method is carried out as follows.

Взвесь эритроцитов третьей фракции, полученную из пробирки с кровью человекаThe suspension of erythrocytes of the third fraction obtained from a test tube with human blood

не.позднее суток с момента вз ти , отмывают стерильным физиологическим раствором IMaCI в соотношении 1-5 не менее 4 раз с осаждением центрифугированием в режиме 1000 об./мин в течение 3 мин. После последнего отмывани  тщательно удал ют надосадочную жидкость, и в пробирку с эритроцитами добавл ют консервирующий раствор следующего состава, в г: сорбит 4,0± 1,0; глюкоза 0,6 0,05; N32HP04 -12Н20 0,02; КНаРОз 0,09; этиловый спирт 96% 9,4 ± 0,4; левомицетин 0,05± 0,01; салицилова  кислота 0,04± 0.005; бидистиллиро- ванна  вода до 100. рН раствора 6,8-6,9, в объемном соотношении эритромасса - консервирующий раствор, равном 1:1. После маркировки пробирку с взвесью консервированных эритроцитов закрывают с по00not later than 24 hours from the moment of taking, wash with sterile saline IMaCI in a ratio of 1-5 at least 4 times with sedimentation by centrifugation at 1000 rpm for 3 minutes. After the last wash, the supernatant is carefully removed, and a preservative solution of the following composition is added to a tube with red blood cells, in g: sorbitol 4.0 ± 1.0; glucose 0.6 0.05; N32HP04 -12H20 0.02; KNARO 0.09; ethyl alcohol 96% 9.4 ± 0.4; chloramphenicol 0.05 ± 0.01; salicylic acid 0.04 ± 0.005; bidistilled water up to 100. The pH of the solution is 6.8–6.9, in a volume ratio of erythromass — a preservative solution equal to 1: 1. After marking the tube with a suspension of preserved erythrocytes is closed with p00

VJVj

OsOs

оabout

мощью фольги или лейкопластыр  и хран т в холодильнике при +4°С. Перед употреблением в пробирку добавл ют физиологический раствор NaCI в количестве, в 5-6 раз превышающем объем взвеси эритроцитов. Затем эритроциты 2 раза отмывают в течение 3 мин с осаждением посредством центрифугировани  в режиме 1000 об/мин.by foil or adhesive plaster and stored in a refrigerator at + 4 ° C. Before use, physiological NaCI solution is added to the tube in an amount that is 5-6 times higher than the volume of erythrocyte suspension. Then, erythrocytes are washed 2 times for 3 minutes with sedimentation by centrifuging at 1000 rpm.

Агглютинабельные свойства эритроцитов (титр), консервированных предложенным и известным способами после 8-недельного хранени  представлены в таблице ,The agglutinable properties of erythrocytes (titer) preserved by the proposed and known methods after 8 weeks storage are presented in the table,

Использование данного способа позвол ет исключить операцию стерилизации приготовленного консервирующего раствора в автоклаве, операцию отсасывани  плазмы и разлива эритроцитов с применением специального оборудовани  с помощью стерильных систем и герметичного укупоривани .The use of this method makes it possible to exclude the operation of sterilization of the prepared preservative solution in the autoclave, the operation of plasma suction and red cell spill using special equipment using sterile systems and hermetic closure.

Claims (1)

Формулаизобретени Invention Formula Способ консервировани  эритроцитов крови дл  изосерологических исследований путем обработки эритромассы раствором, содержащим сорбит, глюкозу, этиловый спирт, левомицетин и натрий двузамещенA method of preserving red blood cells for isoserological studies by treating erythromass with a solution containing sorbitol, glucose, ethyl alcohol, chloramphenicol and sodium is disubstituted ный, калий однозамещенный фосфорнокислые , отличаю щи и с   тем, что, с целью упрощени  способа за счет исключени  энергоемких операций, используют эритро- массу из крови без стабилизирующего раствора , клетки отмывают многократно 0,9%-ным раствором хлористого натри , а обработку осуществл ют при рН 6.8-6,9 в растворе, дополнительно содержащем салициловую кислоту, при следующем соотношении ингредиентов, мас.%:potassium monobasic phosphate, differing in the fact that, in order to simplify the process by eliminating energy-intensive operations, erythromas are taken from blood without a stabilizing solution, cells are washed many times with 0.9% sodium chloride solution, and at pH 6.8-6.9 in solution, additionally containing salicylic acid, in the following ratio of ingredients, wt.%: 5five 00 5five 00 Сорбит Глюкоза Этиловый спирт 96% Левомицетин НатрийSorbitol Glucose Ethyl alcohol 96% Levomitsetin Sodium фосфорнокислый двуза- мещенный Калий фосфорнокислый однозамещенный Салицилова potassium phosphate monosubstituted Potassium phosphate monosubstituted Salitsilova кислота Бидистиллиро- ванна  водаacid Double-distilled water 4,0 ±1,0 0.6± 0.054.0 ± 1.0 0.6 ± 0.05 9,4± 0,4 0.05± 0,019.4 ± 0.4 0.05 ± 0.01 0,20.2 0,090.09 0,04 ± 0,005 До 1000.04 ± 0.005 to 100
SU904806438A 1990-01-30 1990-01-30 Method for preserving the blood erythrocytes SU1718766A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU904806438A SU1718766A1 (en) 1990-01-30 1990-01-30 Method for preserving the blood erythrocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU904806438A SU1718766A1 (en) 1990-01-30 1990-01-30 Method for preserving the blood erythrocytes

Publications (1)

Publication Number Publication Date
SU1718766A1 true SU1718766A1 (en) 1992-03-15

Family

ID=21504055

Family Applications (1)

Application Number Title Priority Date Filing Date
SU904806438A SU1718766A1 (en) 1990-01-30 1990-01-30 Method for preserving the blood erythrocytes

Country Status (1)

Country Link
SU (1) SU1718766A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535421B2 (en) 2009-10-12 2013-09-17 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
RU2495568C1 (en) * 2012-05-23 2013-10-20 Общество с ограниченной ответственностью "ФАРМКОНСАЛТИНГ" (ООО "ФАРМКОНСАЛТИНГ") Method of preserving donor erythrocyte mass
US8569052B2 (en) 2009-10-12 2013-10-29 New Health Sciences, Inc. Oxygen depletion devices and methods for removing oxygen from red blood cells
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
US9005343B2 (en) 2010-05-05 2015-04-14 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US9339025B2 (en) 2010-08-25 2016-05-17 New Health Sciences, Inc. Method for enhancing red blood cell quality and survival during storage
US9801784B2 (en) 2015-04-23 2017-10-31 New Health Sciences, Inc. Anaerobic blood storage containers
US9877476B2 (en) 2013-02-28 2018-01-30 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
US10058091B2 (en) 2015-03-10 2018-08-28 New Health Sciences, Inc. Oxygen reduction disposable kits, devices and methods of use thereof
US10136635B2 (en) 2010-05-05 2018-11-27 New Health Sciences, Inc. Irradiation of red blood cells and anaerobic storage
US10583192B2 (en) 2016-05-27 2020-03-10 New Health Sciences, Inc. Anaerobic blood storage and pathogen inactivation method
US11013771B2 (en) 2015-05-18 2021-05-25 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Временна конструкци по консервированию стандартных эритроцитов и их применение в изосерологических исследовани х. МЗ СССР, №06-14/11, 02.07.79. *

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
US9844615B2 (en) 2009-10-12 2017-12-19 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US11433164B2 (en) 2009-10-12 2022-09-06 Hemanext Inc. System for extended storage of red blood cells and methods of use
US8535421B2 (en) 2009-10-12 2013-09-17 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
US9296990B2 (en) 2009-10-12 2016-03-29 New Health Sciences, Inc. Oxygen depletion devices and methods for removing oxygen from red blood cells
US9095662B2 (en) 2009-10-12 2015-08-04 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
US8569052B2 (en) 2009-10-12 2013-10-29 New Health Sciences, Inc. Oxygen depletion devices and methods for removing oxygen from red blood cells
US10603417B2 (en) 2009-10-12 2020-03-31 Hemanext Inc. System for extended storage of red blood cells and methods of use
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9539375B2 (en) 2010-05-05 2017-01-10 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device
US10065134B2 (en) 2010-05-05 2018-09-04 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device
US9005343B2 (en) 2010-05-05 2015-04-14 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device
US10136635B2 (en) 2010-05-05 2018-11-27 New Health Sciences, Inc. Irradiation of red blood cells and anaerobic storage
US9339025B2 (en) 2010-08-25 2016-05-17 New Health Sciences, Inc. Method for enhancing red blood cell quality and survival during storage
US10251387B2 (en) 2010-08-25 2019-04-09 New Health Sciences, Inc. Method for enhancing red blood cell quality and survival during storage
US9968718B2 (en) 2011-03-28 2018-05-15 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
RU2495568C1 (en) * 2012-05-23 2013-10-20 Общество с ограниченной ответственностью "ФАРМКОНСАЛТИНГ" (ООО "ФАРМКОНСАЛТИНГ") Method of preserving donor erythrocyte mass
US9877476B2 (en) 2013-02-28 2018-01-30 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
US10687526B2 (en) 2013-02-28 2020-06-23 Hemanext Inc. Gas depletion and gas addition devices for blood treatment
US11638421B2 (en) 2015-03-10 2023-05-02 Hemanext Inc. Oxygen reduction disposable kits, devices and methods of use thereof
US10058091B2 (en) 2015-03-10 2018-08-28 New Health Sciences, Inc. Oxygen reduction disposable kits, devices and methods of use thereof
US11375709B2 (en) 2015-03-10 2022-07-05 Hemanext Inc. Oxygen reduction disposable kits, devices and methods of use thereof
US11350626B2 (en) 2015-03-10 2022-06-07 Hemanext Inc. Oxygen reduction disposable kits, devices and methods of use thereof (ORDKit)
US9801784B2 (en) 2015-04-23 2017-10-31 New Health Sciences, Inc. Anaerobic blood storage containers
US10849824B2 (en) 2015-04-23 2020-12-01 Hemanext Inc. Anaerobic blood storage containers
US11013771B2 (en) 2015-05-18 2021-05-25 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
US11147876B2 (en) 2016-05-27 2021-10-19 Hemanext Inc. Anaerobic blood storage and pathogen inactivation method
US10583192B2 (en) 2016-05-27 2020-03-10 New Health Sciences, Inc. Anaerobic blood storage and pathogen inactivation method
US11911471B2 (en) 2016-05-27 2024-02-27 Hemanext Inc. Anaerobic blood storage and pathogen inactivation method

Similar Documents

Publication Publication Date Title
SU1718766A1 (en) Method for preserving the blood erythrocytes
EP0108588B1 (en) Plasma-free medium for platelet storage and its production
EP0044864B2 (en) Red cell storage solution
US6368298B1 (en) Preparing autologous fibrin glue
US3864478A (en) Storage-stable hemoglobin solutions and method for their preparation
KR890009409A (en) Compositions and methods of assisting organs suitable for organ preservation and storage
WO2014106091A1 (en) Solution for preserving vascular conduits
Huggins Prevention of hemolysis of large volumes of red blood cells slowly frozen and thawed in the presence of dimethylsulfoxide
DK160181B (en) APPLICATION OF A HEAT STERILIZABLE Aqueous SOLUTION FOR STORAGE OF RED BLOOD BODIES, A COMPOSITE BLOOD POSITION SYSTEM INCLUDING A POSITION WITH SUCH Aqueous SOLUTION, AND A HEAT STERILIZABLE BLOOD BASKET OF PLASTIC BASED IN PLASTIC USE
BRPI1007666B1 (en) METHOD FOR PREPARING A COMPOUND FROM BLOOD AND EXTRACTION DEVICE
US11291201B2 (en) Solutions for increasing the stability and shelf life of an organ and tissue preservation solution
JPS6363616A (en) Preservation agent for concentrated erythrocyte liquid and method for preservation
CN115244167A (en) Preservation container for cell-containing solution and preservation solution
Davson Studies on the permeability of erythrocytes
US4314025A (en) Blood preservation anticoagulant solution
US6194138B1 (en) Method for flushing blood cells using gelatin
AU6786681A (en) Red cell storage solution
Ikejiani Studies in Trypanosomiasis. III. The Plasma, Whole Blood and Erythrocyte Potassium of Rats during the Course of Infection with Trypanosoma brucei and Trypanosoma equiperdum
RU2775220C1 (en) Preservative for storing native standard red blood cells
CN115633679B (en) Separation preservation solution and separation method for platelet-rich plasma
Korsak et al. Evaluation of two distinct cryoprotectants for cryopreservation of human red blood cell concentrates
RU2225692C2 (en) Preserving agent for washed out erythrocytes
WO2024070504A1 (en) Blood storage composition, and blood sampling vessel
WO2000033853A1 (en) Anti-coagulation with calcium containing citrate solution
Fazekas et al. DESTRUCTION OF INFLUENZA VIRUS RECEPTORS IN THE MOUSE LUNG BY AN ENZYME FROM V. CHOLERAE.